By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


RXi Pharmaceuticals 

1500 West Park Drive
Suite 210
Westborough  Massachusetts  01581  U.S.A.
Phone: 508-767-3861 Fax: 508-767-3862


Company News
RXi Pharmaceuticals (RXII) Announces Advancements In Its Ophthalmology Clinical Program With RXI-109 8/31/2015 6:53:18 AM
RXi Pharmaceuticals (RXII) Reports Second Quarter 2015 Financial Results And Business Highlights 8/12/2015 7:55:36 AM
RXi Pharmaceuticals (RXII) To Webcast Second Quarter 2015 Financial Results On Wednesday, August 12, 2015 7/30/2015 10:04:24 AM
RXi Pharmaceuticals (RXII) Strengthens Intellectual Property Portfolio For Novel RNAi Platform 6/9/2015 6:50:19 AM
RXi Pharmaceuticals (RXII) Granted Notice Of Allowance For Patent Covering Lead Compound, RXI-109, For Use In The Eye 6/3/2015 9:25:26 AM
RXi Pharmaceuticals (RXII)' CEO Dr. Geert Cauwenbergh Interviewed By The Life Sciences Report 6/2/2015 1:00:04 PM
RXi Pharmaceuticals (RXII) To Present At The 23rd World Congress Of Dermatology 6/2/2015 12:34:06 PM
RXi Pharmaceuticals (RXII) Announces Proposed Public Offering Of Common Stock And Warrants 5/28/2015 7:16:06 AM
RXi Pharmaceuticals (RXII) Announces $10 Million Public Offering Of Common Stock And Warrants 5/28/2015 6:46:03 AM
RXi Pharmaceuticals (RXII) Provides An Update On Series A And Series A-1 Preferred Stock 5/27/2015 7:01:34 AM